Knud Landmark
Research Subjects
Knud Landmark has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
A Reikvam
3 shared publications- Ivar Aursnes
Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern 0316 Oslo
2 shared publications F G Lilleås
1 shared publicationIvar Aursnes
University of Oslo
1 shared publicationP Eldevik
1 shared publication
Latest Publications
- 20 February 2002
- Vol. 122 (5) , 499-501
[Hypokalemia can accelerate the development of cerebrovascular and cardiovascular disease].
Hypokalaemia is known to precipitate cardiac arrhythmias. Hypokalaemia can also give rise to adverse cardiovascular effects not related to arrhythmias. This article presents an evaluation of the relevant literature describing adverse effects of hypokalaemia and beneficial effects of potassium supplementation on cerebrovascular and cardiovascular disease. Diuretics-induced hypokalaemia may offset the beneficial effects of blood pressure reduction on cardiovascular events. In several epidemiological studies high intake of potassium in the food was associated with reduced risk of developing a stroke. Fruit and vegetables contain potassium, and an inverse correlation between intake of these nutrients and stroke has been described. In spontaneously hypertensive rats, potassium supplementation in the diet markedly reduced the risk of death, brain haemorrhage and infarct. Potassium reduces oxidative stress and proliferation of smooth muscle cells, i.e. factors involved in the development of atherosclerosis, and may have an antithrombotic effect.
- 20 February 2002
- Vol. 122 (5) , 499-501
[Hypokalemia can accelerate the development of cerebrovascular and cardiovascular disease].
Hypokalaemia is known to precipitate cardiac arrhythmias. Hypokalaemia can also give rise to adverse cardiovascular effects not related to arrhythmias. This article presents an evaluation of the relevant literature describing adverse effects of hypokalaemia and beneficial effects of potassium supplementation on cerebrovascular and cardiovascular disease. Diuretics-induced hypokalaemia may offset the beneficial effects of blood pressure reduction on cardiovascular events. In several epidemiological studies high intake of potassium in the food was associated with reduced risk of developing a stroke. Fruit and vegetables contain potassium, and an inverse correlation between intake of these nutrients and stroke has been described. In spontaneously hypertensive rats, potassium supplementation in the diet markedly reduced the risk of death, brain haemorrhage and infarct. Potassium reduces oxidative stress and proliferation of smooth muscle cells, i.e. factors involved in the development of atherosclerosis, and may have an antithrombotic effect.
- 20 June 2001
- Vol. 121 (16) , 1923-6
[Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Angiotensin-converting enzyme is probably involved in the pathogenesis and progression of atherosclerosis, both through an increase in vascular angiotensin II and by an effect on the degradation of bradykinin into inactive fragments. Moreover, angiotensin II has a prothrombotic effect and prevails in increased concentration in the blood of animals subjected to experimentally induced myocardial infarction. We have evaluated the relevant literature (including animal experiments and human studies) describing the infarct-reducing and anti-ischaemic effects of angiotensin-converting enzyme inhibitors. We also refer to studies in which these drugs have reduced the progression of atherosclerosis. Angiotensin-converting enzyme inhibitors probably have favourable effects in various ways. There are indications that they counteract ischaemia, reduce heart failure and prevent reinfarction. Experimental observations in animals also indicate that angiotensin-converting enzyme inhibitors limit myocardial injury, presumably in part through the effects of bradykinin. This is supported by some few clinical studies, including a Norwegian epidemiological study. Angiotensin-converting enzyme inhibitors reduced the progression of intima-media thickness in the carotid arteries. Angiotensin-converting enzyme inhibitors have favourable biochemical and haemodynamic properties that may explain their beneficial effects in patients with coronary heart failure.
- 20 June 2001
- Vol. 121 (16) , 1923-6
[Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Angiotensin-converting enzyme is probably involved in the pathogenesis and progression of atherosclerosis, both through an increase in vascular angiotensin II and by an effect on the degradation of bradykinin into inactive fragments. Moreover, angiotensin II has a prothrombotic effect and prevails in increased concentration in the blood of animals subjected to experimentally induced myocardial infarction. We have evaluated the relevant literature (including animal experiments and human studies) describing the infarct-reducing and anti-ischaemic effects of angiotensin-converting enzyme inhibitors. We also refer to studies in which these drugs have reduced the progression of atherosclerosis. Angiotensin-converting enzyme inhibitors probably have favourable effects in various ways. There are indications that they counteract ischaemia, reduce heart failure and prevent reinfarction. Experimental observations in animals also indicate that angiotensin-converting enzyme inhibitors limit myocardial injury, presumably in part through the effects of bradykinin. This is supported by some few clinical studies, including a Norwegian epidemiological study. Angiotensin-converting enzyme inhibitors reduced the progression of intima-media thickness in the carotid arteries. Angiotensin-converting enzyme inhibitors have favourable biochemical and haemodynamic properties that may explain their beneficial effects in patients with coronary heart failure.
- 20 June 2001
- Vol. 121 (16) , 1937-9
[Low-dosage acetylsalicylic acid as primary prevention against cardiovascular disease].
- 20 June 2001
- Vol. 121 (16) , 1937-9
[Low-dosage acetylsalicylic acid as primary prevention against cardiovascular disease].
- 30 May 2001
- Vol. 121 (14) , 1710-2
[Smoking and coronary heart disease].
Smoking increases the risk of developing coronary heart disease in men and women. Several epidemiological studies have demonstrated an almost linear relationship between smoking and coronary heart mortality and morbidity, the risk being more than twofold and most pronounced in younger individuals. Smokers are younger than nonsmokers when they suffer their first myocardial infarction, more of them are males, and they experience more frequently posterior infarcts. They are likely to develop right coronary occlusions, the lesions being rather thrombogenic than atherosclerotic. This phenomenon may partly be related to the specific flow pattern in the right coronary artery. Passive smoking is harmful. Quitting smoking in patients and in healthy individuals reduces the risk markedly within a short period of time. Smoking causes vasoconstriction of coronary arteries, and endothelial function as well as fibrinolysis is impaired while platelets are activated. A human ex-vivo experimental model has shown that the thrombus volume was increased twofold in blood from smokers at shear forces that are found in moderately stenosed coronary arteries. In addition, smokers are insulin-resistant and at increased risk of developing diabetes mellitus.
- 30 May 2001
- Vol. 121 (14) , 1710-2
[Smoking and coronary heart disease].
Smoking increases the risk of developing coronary heart disease in men and women. Several epidemiological studies have demonstrated an almost linear relationship between smoking and coronary heart mortality and morbidity, the risk being more than twofold and most pronounced in younger individuals. Smokers are younger than nonsmokers when they suffer their first myocardial infarction, more of them are males, and they experience more frequently posterior infarcts. They are likely to develop right coronary occlusions, the lesions being rather thrombogenic than atherosclerotic. This phenomenon may partly be related to the specific flow pattern in the right coronary artery. Passive smoking is harmful. Quitting smoking in patients and in healthy individuals reduces the risk markedly within a short period of time. Smoking causes vasoconstriction of coronary arteries, and endothelial function as well as fibrinolysis is impaired while platelets are activated. A human ex-vivo experimental model has shown that the thrombus volume was increased twofold in blood from smokers at shear forces that are found in moderately stenosed coronary arteries. In addition, smokers are insulin-resistant and at increased risk of developing diabetes mellitus.
- 28 February 2001
- Vol. 121 (6) , 701-5
[Are the newer antihypertensive agents better and more effective than diuretics?].
In recent years, the expenses for medical antihypertensive therapy have increased considerably, the main reason being the switchover to newer and more expensive antihypertensive drugs. Several recent studies which have compared the efficacy of the older, conventional drugs (thiazid diuretics and beta-blockers) with the newer agents (calcium blockers, angiotensin-converting enzyme (ACE) inhibitors), have shown that they are almost equipotent with regard to effects on blood pressure, morbidity and mortality. At lower doses, the metabolic effects of thiazide diuretics are minimal and probably without clinical significance, and the risk of developing diabetes mellitus type 2 does not seem to be increased. The cheaper thiazide diuretics are still valuable drugs in the treatment of hypertension. If more than one agent is necessary to reduce blood pressure to the desired level, they can be combined with other antihypertensive agents.
- 28 February 2001
- Vol. 121 (6) , 701-5
[Are the newer antihypertensive agents better and more effective than diuretics?].
In recent years, the expenses for medical antihypertensive therapy have increased considerably, the main reason being the switchover to newer and more expensive antihypertensive drugs. Several recent studies which have compared the efficacy of the older, conventional drugs (thiazid diuretics and beta-blockers) with the newer agents (calcium blockers, angiotensin-converting enzyme (ACE) inhibitors), have shown that they are almost equipotent with regard to effects on blood pressure, morbidity and mortality. At lower doses, the metabolic effects of thiazide diuretics are minimal and probably without clinical significance, and the risk of developing diabetes mellitus type 2 does not seem to be increased. The cheaper thiazide diuretics are still valuable drugs in the treatment of hypertension. If more than one agent is necessary to reduce blood pressure to the desired level, they can be combined with other antihypertensive agents.
- 10 January 2001
- Vol. 121 (1) , 97-8
[Meta-analyses, magnesium and acute myocardial infarction].
- 1 December 2000
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 20 (6) , 415-423
Infarct Size as Assessed by Peak Enzyme Levels is Reduced in Patients Who Are Using Angiotensin-Converting Enzyme Inhibitors at the Onset of Infarction
- 1 December 2000
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 20 (6) , 415-423
Infarct Size as Assessed by Peak Enzyme Levels is Reduced in Patients Who Are Using Angiotensin-Converting Enzyme Inhibitors at the Onset of Infarction
- 20 September 2000
- Vol. 120 (22) , 2648-53
[Nutrition, dietary supplementation and coronary heart disease].
During the last decade, lipid lowering agents, in particular statins, have become increasingly important in the treatment of cardiovascular diseases and dyslipidaemias. This might imply that emphasis on diet and supplementary nutrients do not receive sufficient attention. On the basis of studies of the literature, the scientific documentation for a possible beneficial effect of the following elements are reviewed: intake of fat, fish and fish oil, alpha-linolenic acid, folic acid, vitamin B6 and vitamin B12, nuts, plant sterols and psyllium. Reduced intake of saturated fat causes improvement in serum lipid values and prevents cardiovascular events. Intake of fish, fish oils and alpha-linolenic acid has positive effects on several clinical end points, often without marked decrease in serum cholesterol. Homocysteine appears to be an independent risk factor for cardiovascular diseases, but a causal relationship remains to be proven. The cofactors folic acid, vitamin B6 and B12 reduce the homocysteine level, but effects of this intervention on hard clinical end points are lacking. There are indications that intake of nuts can prevent coronary events. Plant sterols and psyllium in the diet reduce cholesterol levels. Thus, dietary intervention is important in the prevention and treatment of coronary heart disease. Also when drug treatment is indicated, a focus on diet and nutrient supplementation is highly warranted. Some nutrients may have preventive effect in relation to coronary events, despite their small effect on cholesterol levels.
- 20 September 2000
- Vol. 120 (22) , 2648-53
[Nutrition, dietary supplementation and coronary heart disease].
During the last decade, lipid lowering agents, in particular statins, have become increasingly important in the treatment of cardiovascular diseases and dyslipidaemias. This might imply that emphasis on diet and supplementary nutrients do not receive sufficient attention. On the basis of studies of the literature, the scientific documentation for a possible beneficial effect of the following elements are reviewed: intake of fat, fish and fish oil, alpha-linolenic acid, folic acid, vitamin B6 and vitamin B12, nuts, plant sterols and psyllium. Reduced intake of saturated fat causes improvement in serum lipid values and prevents cardiovascular events. Intake of fish, fish oils and alpha-linolenic acid has positive effects on several clinical end points, often without marked decrease in serum cholesterol. Homocysteine appears to be an independent risk factor for cardiovascular diseases, but a causal relationship remains to be proven. The cofactors folic acid, vitamin B6 and B12 reduce the homocysteine level, but effects of this intervention on hard clinical end points are lacking. There are indications that intake of nuts can prevent coronary events. Plant sterols and psyllium in the diet reduce cholesterol levels. Thus, dietary intervention is important in the prevention and treatment of coronary heart disease. Also when drug treatment is indicated, a focus on diet and nutrient supplementation is highly warranted. Some nutrients may have preventive effect in relation to coronary events, despite their small effect on cholesterol levels.
- 1 January 2000
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 34 (1) , 73-78
Current Smokers Develop More Posterior Myocardial Infarctions Probably Due to Increased Tendency to Thrombosis
This investigation was carried out to determine whether smokers developed smaller infarcts as assessed by peak enzyme levels and also to what extent smoking could modify infarct localization. The study included 753 patients, of whom 351 had no history of previous coronary heart disease (CHD) (angina pectoris and/or myocardial infarction (MI)). The investigation was designed as an exposed (smoking) versus non-exposed (non-smoking) cohort study. Outcome was infarct size, posterior versus non-posterior MI and non-Q-wave versus Q-wave infarcts. In the total cohort of patients, 312 (41%) were smokers, the corresponding number in the restricted cohort of patients without a previous CHD (CHD-0-pts) was 169 (48%). Smokers were younger than non-smokers, and more of them were males. It was found that infarct size was similar in smokers and in non-smokers (crude and adjusted effects). Crude effects showed that smokers developed significantly more posterior infarcts than non-smokers; odds ratio (OR) for developing a posterior MI was 1.95 (2p < 0.001) (all patients) and 2.34 (2< 0.001) (CHD-0-pts), respectively. After adjusting for confounders (logistic regression model), OR in the two groups was 1.24 (2p = 0.256) and 1.95 (2p = 0.01), respectively. The study shows that current smokers were younger, and indicates that in those without a previous CHD, significantly more of them developed a posterior MI.
- 1 January 2000
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 34 (1) , 73-78
Current Smokers Develop More Posterior Myocardial Infarctions Probably Due to Increased Tendency to Thrombosis
This investigation was carried out to determine whether smokers developed smaller infarcts as assessed by peak enzyme levels and also to what extent smoking could modify infarct localization. The study included 753 patients, of whom 351 had no history of previous coronary heart disease (CHD) (angina pectoris and/or myocardial infarction (MI)). The investigation was designed as an exposed (smoking) versus non-exposed (non-smoking) cohort study. Outcome was infarct size, posterior versus non-posterior MI and non-Q-wave versus Q-wave infarcts. In the total cohort of patients, 312 (41%) were smokers, the corresponding number in the restricted cohort of patients without a previous CHD (CHD-0-pts) was 169 (48%). Smokers were younger than non-smokers, and more of them were males. It was found that infarct size was similar in smokers and in non-smokers (crude and adjusted effects). Crude effects showed that smokers developed significantly more posterior infarcts than non-smokers; odds ratio (OR) for developing a posterior MI was 1.95 (2p < 0.001) (all patients) and 2.34 (2< 0.001) (CHD-0-pts), respectively. After adjusting for confounders (logistic regression model), OR in the two groups was 1.24 (2p = 0.256) and 1.95 (2p = 0.01), respectively. The study shows that current smokers were younger, and indicates that in those without a previous CHD, significantly more of them developed a posterior MI.
- 10 October 1998
- Vol. 118 (24) , 3805-9
[The effect of reduced cholesterol on coronary arteries].
High levels of cholesterol increase the influx of calcium ions into vascular smooth muscle cells, thereby increasing vascular tone and resistance. Simultaneously, endothelium-dependent (NO-mediated) vasodilatation is inhibited in the arteries. Brief reductions in cholesterol induced by dietary intervention or with lipid lowering therapy normalize endothelial dysfunction, and myocardial perfusion will increase well before any beneficial effects on atherosclerosis are detected. These phenomena may explain, at least in part, that in spite of even small differences in angiographic findings between patients who have undergone treatment and those who have not, lowering lipids will cause major reductions in cardiovascular events. Lowering the levels of cholesterol will alter the content and composition of atherosclerotic plaques, thereby making them more stable. The result is probably a substantial reduction in the frequency of plaque rupture, and if rupture should occur, the thrombotic mechanisms will probably be weaker. Consequently, the risk of a thrombotic occlusion of a coronary vessel will be reduced.
- 10 October 1998
- Vol. 118 (24) , 3805-9
[The effect of reduced cholesterol on coronary arteries].
High levels of cholesterol increase the influx of calcium ions into vascular smooth muscle cells, thereby increasing vascular tone and resistance. Simultaneously, endothelium-dependent (NO-mediated) vasodilatation is inhibited in the arteries. Brief reductions in cholesterol induced by dietary intervention or with lipid lowering therapy normalize endothelial dysfunction, and myocardial perfusion will increase well before any beneficial effects on atherosclerosis are detected. These phenomena may explain, at least in part, that in spite of even small differences in angiographic findings between patients who have undergone treatment and those who have not, lowering lipids will cause major reductions in cardiovascular events. Lowering the levels of cholesterol will alter the content and composition of atherosclerotic plaques, thereby making them more stable. The result is probably a substantial reduction in the frequency of plaque rupture, and if rupture should occur, the thrombotic mechanisms will probably be weaker. Consequently, the risk of a thrombotic occlusion of a coronary vessel will be reduced.